Industry groups express misgivings on FDA’s QMM program
Regulatory NewsJoanne S. Eglovitch
GenericsNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory NewsJoanne S. EglovitchGenericsNorth AmericaPharmaceuticalsQuality Assurance and Control